Anaplastic lymphoma kinase (ALK) rearrangements occur in approximately 2% to 7% of non-small cell lung cancer (NSCLC) patients and are more common among younger aged patients with no or light smoking history2–6. The gene discussed is ALK; the disease is non-small cell lung carcinoma.